Literature DB >> 35303829

An unusual occurrence of opsoclonus and liver enzymes elevation in a patient with acute motor and sensory axonal neuropathy subtype of Guillain-Barré syndrome.

Hasan Alzuhaily1, Eman Khashaneh2, Sanaa Albkhetan3, Fatima Abbas4.   

Abstract

BACKGROUND: Acute motor and sensory axonal neuropathy (AMSAN) is a subtype of Guillain-Barré syndrome (GBS) differentiated by nerve conduction studies (NCS) and characterized by symmetric ascending paralysis often involving respiratory muscles. While opsoclonus, which is involuntary chaotic rapid eye movements, is not a common manifestation of GBS. Moreover, little published data are available on the relation between liver enzymes elevation and GBS. CASE
PRESENTATION: A 42-year-old man presented to Al Mouwassat University Hospital with weakness in all limbs and dyspnea. Examination showed an elevated respiratory rate, hyporeflexia, and decreased strength of upper and lower limbs. Analysis of cerebrospinal fluid revealed an albuminocyto-dissociation suggesting the diagnosis of GBS and subsequent plasmapheresis. NCS confirmed a diagnosis of AMSAN. Elevation in liver enzymes was noticed prompting further exploration with no positive findings. Despite treatment efforts, the patient developed severe dyspnea, deterioration in cognitive abilities, and opsoclonus with a normal brain MRI. Unfortunately, he developed respiratory failure which lead to his death.
CONCLUSION: In this case, we highlight the occurrence of opsoclonus which is a rarely-encountered manifestation of GBS, in addition to an unexplained elevated liver enzyme, the thing that could contribute to larger research to further comprehend the pathophysiology of GBS.
© 2022. The Author(s).

Entities:  

Keywords:  Case Report; Eye Movements; Guillain-Barré syndrome; Liver Disease; Opsoclonus

Mesh:

Year:  2022        PMID: 35303829      PMCID: PMC8932169          DOI: 10.1186/s12883-022-02599-0

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  16 in total

1.  Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome.

Authors:  R P Kleyweg; F G van der Meché; P I Schmitz
Journal:  Muscle Nerve       Date:  1991-11       Impact factor: 3.217

2.  Guillain-Barré syndrome in the 100 years since its description by Guillain, Barré and Strohl.

Authors:  Richard A C Hughes; David R Cornblath; Hugh J Willison
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

3.  Opsoclonus in a patient with Guillain-Barré syndrome.

Authors:  A Nicolai; L G Lazzarino
Journal:  Acta Neurol Scand       Date:  1992-05       Impact factor: 3.209

4.  Guillain-Barré syndrome in northwest Greece.

Authors:  S Markoula; S Giannopoulos; I Sarmas; S Tzavidi; A P Kyritsis; G Lagos
Journal:  Acta Neurol Scand       Date:  2007-03       Impact factor: 3.209

5.  Single breath counting in the assessment of pulmonary function.

Authors:  J M Bartfield; B S Ushkow; J M Rosen; K Dylong
Journal:  Ann Emerg Med       Date:  1994-08       Impact factor: 5.721

6.  New York Heart Association functional class predicts exercise parameters in the current era.

Authors:  Stuart D Russell; Matthew A Saval; Jennifer L Robbins; Myrvin H Ellestad; Stephen S Gottlieb; Eileen M Handberg; Yi Zhou; Bleakley Chandler
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

7.  Liver function disturbances in Guillain-Barré syndrome: a prospective longitudinal study in 100 patients. Dutch Guillain-Barré Study Group.

Authors:  P G Oomes; F G van der Meché; R P Kleyweg
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

Review 8.  Update on opsoclonus-myoclonus syndrome in adults.

Authors:  Sun-Young Oh; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2018-11-27       Impact factor: 4.849

9.  Risk factors for the severity of Guillain-Barré syndrome and predictors of short-term prognosis of severe Guillain-Barré syndrome.

Authors:  Puyuan Wen; Lisha Wang; Hong Liu; Li Gong; Han Ji; Hongliang Wu; Wenzheng Chu
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

10.  A 30-Year-Old Man with Acute Motor Axonal Neuropathy Subtype of Guillain-Barré Syndrome Having Hepatitis A Virus Infection.

Authors:  Alireza Samadi; Fariborz Mansour-Ghanaei; Farahnaz Joukar; Sara Mavaddati; Iman Sufi Afshar
Journal:  Middle East J Dig Dis       Date:  2019-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.